fbpx

Health Care

Advaxis names new CEO

Advaxis Inc., a Princeton biotech specializing in drugs treating cancer and infectious diseases, today named Daniel J. O'Connor as CEO, replacing Thomas Moore, who will continue to serve on the board of directors and as a consultant to the company.

Read More »